313 related articles for article (PubMed ID: 30557819)
21. Oropharyngeal HPV infection: prevalence and sampling methods among HIV-infected men in South Africa.
Chikandiwa A; Pisa PT; Chersich MF; Muller EE; Mayaud P; Delany-Moretlwe S
Int J STD AIDS; 2018 Jul; 29(8):776-780. PubMed ID: 29471764
[TBL] [Abstract][Full Text] [Related]
22. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
23. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
de Martel C; Plummer M; Vignat J; Franceschi S
Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
[TBL] [Abstract][Full Text] [Related]
24. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
25. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
Choi I; Lee D; Son KB; Bae S
BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus (HPV) in head and neck cancer.
Syrjänen S
J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
[TBL] [Abstract][Full Text] [Related]
27. [Infection of human papillomavirus and head and neck cancer].
Song C; Zhang SK; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):39-43. PubMed ID: 36709118
[TBL] [Abstract][Full Text] [Related]
28. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
29. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.
Cole L; Polfus L; Peters ES
PLoS One; 2012; 7(3):e32657. PubMed ID: 22448226
[TBL] [Abstract][Full Text] [Related]
30. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and burden of HPV-related disease.
Serrano B; Brotons M; Bosch FX; Bruni L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
[TBL] [Abstract][Full Text] [Related]
32. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
Wang CC; Palefsky JM
Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
[TBL] [Abstract][Full Text] [Related]
34. Oropharyngeal and laryngeal but not oral cancers are strongly associated with high-risk human papillomavirus in 172 Greek patients.
Tsimplaki E; Argyri E; Sakellaridis A; Kyrodimos E; Xesfyngi D; Panotopoulou E
J Med Virol; 2017 Jan; 89(1):170-176. PubMed ID: 27335246
[TBL] [Abstract][Full Text] [Related]
35. The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.
LeHew CW; Weatherspoon DJ; Peterson CE; Goben A; Reitmajer K; Sroussi H; Kaste LM
Epidemiol Rev; 2017 Jan; 39(1):132-147. PubMed ID: 28402398
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of oral and oropharyngeal human papillomavirus in a sample of South African men: a pilot study.
Davidson CL; Richter KL; Van der Linde M; Coetsee J; Boy SC
S Afr Med J; 2014 Mar; 104(5):358-61. PubMed ID: 25212204
[TBL] [Abstract][Full Text] [Related]
37. Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.
Hwang TZ; Hsiao JR; Tsai CR; Chang JS
Int J Cancer; 2015 Jul; 137(2):395-408. PubMed ID: 25395239
[TBL] [Abstract][Full Text] [Related]
38. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
39. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
Fullerton ZH; Butler SS; Mahal BA; Muralidhar V; Schoenfeld JD; Tishler RB; Margalit DN
Cancer; 2020 Apr; 126(7):1424-1433. PubMed ID: 31930488
[TBL] [Abstract][Full Text] [Related]
40. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
